Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Idorsia Pharmaceuticals Ltd. clinical trials
The registry lists 103 studies whose lead sponsor is Idorsia Pharmaceuticals Ltd.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 28, 2026.
Keep track of what changes. Save the Idorsia Pharmaceuticals Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Idorsia Pharmaceuticals Ltd..
- Idorsia Pharmaceuticals Ltd.103 studiesSame company
Something wrong?
Focus areas
Conditions Idorsia Pharmaceuticals Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 103. Browse all 103 →
- A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During the DayNot yet recruitingNCT07843329Phase 3
- A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry DiseaseNot yet recruitingNCT07778667Phase 3
- Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302AvailableNCT07762638
- A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental VitiligoNot yet recruitingNCT07667569Phase 2
- Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®RecruitingNCT06498128
- A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry DiseaseActive, not recruitingNCT03737214Phase 3
- Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia DisorderCompletedNCT05423717Phase 2
- Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)Active, not recruitingNCT06393504
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy SubjectsCompletedNCT02944474Phase 1
- A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy SubjectsCompletedNCT02944487Phase 1
- A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid NocturiaCompletedNCT05597020Phase 4
- A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal ContraceptivesCompletedNCT06799884Phase 1
- Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry DiseaseCompletedNCT03425539Phase 3
- Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the BrainCompletedNCT03585270Phase 3
- A Phase 1 Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese ParticipantsCompletedNCT05877222Phase 1
- A Study to Measure Daridorexant in Breast Milk of Healthy Lactating WomenCompletedNCT05632393Phase 1
- A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously PresentedCompletedNCT05702177Phase 1
- A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During SleepCompletedNCT05458193Phase 1
- Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating DisorderCompletedNCT04753164Phase 2
- A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its SafetyCompletedNCT03541174Phase 3
- A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)CompletedNCT03245229Phase 1
- A Study to Evaluate ACT-132577 in Healthy Male SubjectsCompletedNCT03100591Phase 1
- Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy SubjectsCompletedNCT02708004Phase 1
- A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male SubjectsCompletedNCT02841761Phase 1
- A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.WithdrawnNCT04162366Phase 3
- Bioequivalence Study of Different Aprocitentan Tablet FormulationsCompletedNCT05196399Phase 1
- The Effect of Hepatic Impairment on Aprocitentan PharmacokineticsCompletedNCT04252495Phase 1
- A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian SubjectsCompletedNCT03586570Phase 1
- To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and WomenCompletedNCT04281342Phase 1
- Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential HypertensionCompletedNCT02603809Phase 2
- A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney DiseaseCompletedNCT03165071Phase 1
- A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male SubjectsCompletedNCT05549531Phase 1
- A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male SubjectsCompletedNCT05480475Phase 1
- A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Midazolam and Warfarin in Healthy Male SubjectsCompletedNCT05480488Phase 1
- A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy SubjectsCompletedNCT04798209Phase 1
- Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy SubjectsCompletedNCT03380455Phase 1
- A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy SubjectsCompletedNCT05254548Phase 1
- A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal PolyposisCompletedNCT03688555Phase 2
- Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia DisorderCompletedNCT03545191Phase 3
- Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to SleepCompletedNCT03575104Phase 3
- Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to SleepCompletedNCT03679884Phase 3
- Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470CompletedNCT05123820Phase 1
- A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control SubjectsCompletedNCT04899219Phase 1
- Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2CompletedNCT04470713
- A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy SubjectsCompletedNCT04608513Phase 1
- A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478TerminatedNCT04452006Phase 1
- Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239CompletedNCT04286750Phase 1
- A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy SubjectsCompletedNCT04250506Phase 1
- A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.CompletedNCT04390334Phase 1
- Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy SubjectsCompletedNCT04024332Phase 1